我们的网站为什么显示成这样？

可能因为您的浏览器不支持样式，您可以更新您的浏览器到最新版本，以获取对此功能的支持，访问下面的网站，获取关于浏览器的信息：

|本期目录/Table of Contents|

转染p53基因对培养的人动脉平滑肌细胞的影响

《心脏杂志》[ISSN:1009-7236/CN:61-1268/R]

期数:
2010年第6期
页码:
856-859
栏目:
基础研究
出版日期:
2010-08-23

文章信息/Info

Title:
Effect of wild-type p53 gene modification on human aortic smooth muscle cell lines
作者:
方五旺; 姜兰兰; 林丙来
皖南医学院附属芜湖市第二人民医院心内二科，安徽 芜湖 241000
Author(s):
FANG Wu-wang;  JIANG Lan-lan;  LIN Bing-lai
Department of Cardiology, Wuhu Second Municipal People’s Hospital, Wuhu 241000, Anhui, China
关键词:
p53基因; 基因转染; 人动脉平滑肌细胞; 细胞凋亡
Keywords:
p53 gene;  gene transfection;  human aortic smooth muscle cells;  cell apoptosis
分类号:
R459.9
DOI:
-
文献标识码:
A
摘要:
目的: 探讨转染野生型p53(wt p53)基因对培养的人动脉平滑肌细胞(HASMCs)的影响，为冠状动脉支架内再狭窄的治疗提供新的思路。方法: 以Lipofectamine 2000脂质体介导wt p53基因转染HASMCs株后，用免疫组化染色法检测转染wt p53基因后，其编码蛋白在HASMCs中的表达。绘制wt p53基因转染后HASMCs的增殖曲线。用WST-1法测定A值，并计算细胞生长的抑制率。用流式细胞仪检测wt p53基因转染对HASMCs凋亡的影响。结果: 免疫组化染色法显示，wt p53基因转染后，在HASMCs的细胞核内高表达；wt p53基因的表达可抑制HASMCs的体外生长。HASMC/wt p53细胞的生长曲线较对照组明显降低；WST-1法显示，HASMC/wt p53的细胞活力与对照组相比有显著性差异(P<0.05)。流式细胞仪检测显示，转染wt p53基因的HASMCs的凋亡率达40%以上，显著高于对照组。结论: 转染wt p53基因对HASMCs具有明显的抑制和凋亡作用，提示wt p53基因转染HASMCs技术有可能为人冠状动脉支架内再狭窄的治疗提供一种新的防治策略与手段。
Abstract:
AIM：To investigate the inhibitory and apoptosis effect of wild-type p53 (wt p53) gene transfection on human aortic smooth muscle cell (HASMC) lines and to explore a new way for prevention of restenosis following coronary artery stenting via wt p53 gene transfection into HASMCs. METHODS: HASMC lines were transfected by wt p53 gene coated by liposome of lipofectamine 2000. The expression of wt p53 protein in HASMC was determined by immunohistochemistry. Cell proliferation and the apoptosis of wt p53 gene on cell growth were detected by cell growth curve, WST-1 assay and flow cytometry. RESULTS: Immunohistochemistry staining showed that the protein of wt p53 gene was expressed in the cellular nucleus of HASMCs. Overexpression of wt p53 gene significantly decreased HASMC proliferation in vitro compared with that of control vector. Growth rate of HASMC/wt p53(+) was significantly lower than control. WST-1 test showed significant differences in cell viability between HASMC/wt p53 and control cells (P<0.05). FCM showed that the rate of HASMC/wt p53 apoptosis was >40%, significantly higher than control cells. CONCLUSION: Transfection of wt p53 gene obviously induces cellular inhibition and apoptosis in HASMCs, suggesting that wt p53 gene transfection into HASMCs can be an effective means for prevention and therapy of restenosis after coronary stenting.

参考文献/References

［1］Baskar R, Sparatore A, Del Soldato P, et al. Effect of S-diclofenac, a novel hydrogen sulfide releasing derivative inhibit rat vascular smooth muscle cell proliferation［J］. Eur J Pharmacol, 2008, 594(1-3):1-8.

［2］Davis BB, Dong Y, Weiss RH. Overexpression of p73 causes apoptosis in vascular smooth muscle cells［J］. Am J Physiol Cell Physiol, 2003, 284(1):C16-C23.

［3］Igata M, Motoshima H, Tsuruzoe K, et al. Adenosine monophosphate-activated protein kinase suppresses vascular smooth muscle cell proliferation through the inhibition of cell cycle progression［J］. Circ Res, 2005, 97(8):837-844.

［4］Jacob T, Ascher E, Hingorani A, et al. The effect of von hippel-lindau gene transfer on human vascular smooth muscle cell proliferation and apoptosis［J］. Vasc Endovascular Surg, 2005, 39(1):25-32.

［5］Selvendiran K, Kuppusamy ML, Bratasz A, et al. Inhibition of vascular smooth-muscle-cell proliferation and arterial restenosis by HO-3867, a novel synthetic curcuminoid, through upregulation of PTEN expression［J］. J Pharmacol Exp Ther, 2009, 329(3):959-966.

［6］Duran X, Vilahur G, Badimon L. Exogenous in vivo NO-donor treatment preserves p53 levels and protects vascular cells from apoptosis［J］. Atherosclerosis, 2009, 205(1):101-106.

［7］Liang KW, Yin SC, Ting CT, et al. Berberine inhibits platelet-derived growth factor-induced growth and migration partly through an AMPK-dependent pathway in vascular smooth muscle cells［J］. Eur J Pharmacol, 2008, 590(1-3):343-354.

［8］Wassmann S, Wassmann K, Jung A, et al. Induction of p53 by GKLF is essential for inhibition of proliferation of vascular smooth muscle cells［J］. J Mol Cell Cardiol, 2007, 43(3):301-307.

[9]Matsushita H, Morishita R, Aoki M, et al. Transfection of antisense p53 tumor suppressor gene oligodeoxynucleotides into rat carotid artery results in abnormal growth of vascular smooth muscle cells［J］. Circulation, 2000,101(12):1447-1452.

[10]Rosner D, McCarthy N, Bennett M. Rapamycin inhibits human in stent restenosis vascular smooth muscle cells independently of pRB phosphorylation and p53［J］. Cardiovasc Res, 2005, 66(3):601-610.

[11]Chan KC, Wang CJ, Ho HH, et al. Simvastatin inhibits cell cycle progression in glucose-stimulated proliferation of aortic vascular smooth muscle cells by up-regulating cyclin dependent kinase inhibitorsCDK and p53［J］. Pharmacol Res, 2008, 58(3-4):247-256.

[12]Morishita R. A scientific rationale for the CREST trial results: evidence for the mechanism of action of cilostazol in restenosis［J］. Atheroscler Suppl, 2005, 6(4):41-46.

[13]Wang X, Zou Y, Sun A, et al. Emodin induces growth arrest and death of human vascular smooth muscle cells through reactive oxygen species and p53［J］. J Cardiovasc Pharmacol, 2007, 49(5):253-260.

备注/Memo

备注/Memo:
收稿日期：2009-08-21.基金项目：芜湖市科技局课题资助(2007-68) 通讯作者：方五旺，主任医师，主要从事冠心病血运重建研究Email:fangwuwang@sina.com
更新日期/Last Update: 2010-08-22